Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBig Technologies Regulatory News (BIG)

Share Price Information for Big Technologies (BIG)

Share Price is delayed by 15 minutes
Get Live Data
105.00    0.50 (0.48%)
Bid:
104.50
Ask:
105.00
Spread: 0.50 (0.478%)
Market Cap: £306.84m
BIG Live PriceLast checked at - London Stock Exchange

Intraday Big Technologies Share Chart

Full Year Trading Update

27 Jan 2026 07:00

RNS Number : 4385Q
Big Technologies PLC
27 January 2026
 

 

Big Technologies plc

("Big Technologies" or "the Company" and, together with its subsidiaries, the 'Group')

 

Full Year Trading Update

 

Rickmansworth - 27 January 2026 - Big Technologies plc (AIM: BIG), a leading provider of electronic monitoring solutions provides the following unaudited trading update for the year ended 31 December 2025 ("FY 25").

Financial Highlights

· The Group has continued to perform strongly and is expected to be marginally ahead of FY 25 market consensus1 for both revenue and adjusted EBITDA2.

 

· Annual Recurring Revenue3 ("ARR") achieved constant currency growth of 12% to £52.4m (31 December 2024: £46.8m, on a constant currency basis4) reflecting strong new business momentum, especially in the Americas which grew 25%.

 

· Unaudited Group revenues of approximately £49.7m (2024: £50.3m). On a constant currency basis4 2024 revenues were £48.1m, representing growth of 3% year on year.

 

· After adjusting for the loss of the Colombia contract in H1 2024, underlying constant currency revenue growth was 9%.

 

· Unaudited adjusted EBITDA2 of approximately £24.6m (2024: £27.0m) reflecting a change in margin mix, and investments made in strengthening the Group's management which, following cost saving action, are expected to be cost neutral in future periods.

 

· Continued to be cash generative with a strong balance sheet at the year end with cash of £93.4m. Including the initial payment of £31.5m paid in relation to the recent settlement of the Buddi Litigation, cash at 31 December 2025 would have been £61.9m.

 

 

Operational Highlights

 

· Further New Business Success having won a contract to provide technology to a partner for a southern European country and a contract in Aruba, complementing the recently announced wins in Lithuania, Latvia, Pierce County and Prince Edward Island. This new business positions the Group strongly to realise growth, as these contracts commence operation in 2026.

 

· New Organisational Structure established in H2 2025 with the appointment of a new leadership team, including regional VPs for the Americas, APAC and EMEA, together with additional new roles in product quality, regulatory & marketing.

 

· US Monitoring Centre established in Tampa, Florida to support the growing customer base in USA.

 

· New Product launched for measuring alcohol in breath, the 'AlcoBreath', with product certification achieved in the USA and Europe, complimenting the AlcoTag product that measures alcohol around the ankle.

 

· Partnership and Technical Integration with Actall Corporation to integrate Buddi's RF tag technology into the Actall HubSensTM RTLS platform, following the successful technical evaluation in Q4 2025. The partnership aims to offer custody and justice operators a unified view of individual movement across both secure in-facility environments and community based supervision.

 

 

Ian Johnson, Big Technologies CEO, said: "I am pleased to report good progress in 2025 despite the contract losses midway through 2024 impacting the year. As a result of our focus on strengthening the management of the Group, new contract momentum has improved. I am very proud of the strong performance of the regional teams who grew ARR by 12% and underlying revenues by 9% on a constant currency basis4.

Building on the solid final quarter of 2025 where we were awarded several new contracts, the Group remains well positioned for further growth in 2026, underpinned by best in class technology, a loyal client base and a robust balance sheet. I look forward to continuing to grow the business in 2026"

 

 

-Ends-

 

This trading update is based upon unaudited management accounts and has been prepared solely to provide additional information on trading to the shareholders of Big Technology Group plc. All figures are provisional and subject to further review.

1 The Group has compiled forecasts from five analysts with current market forecasts for 2025 revenue to be in the range of £48.5m to £49.5m, with consensus of £49.1m, and for adjusted EBITDA to be in the range of £23.7m to £24.5m, with a consensus of £24.1m.

2 Adjusted EBITDA excludes share-based payments and other adjusting items, including but not limited to provisions for legal expenses in relation to ongoing litigation, associated costs relating to the legal proceedings and an exceptional foreign exchange loss of £4.0m relating to funds held in US Dollars in anticipation of a potential acquisition.

3 ARR is the value of continuing revenue from recurring accounts at a specific point in time, normalised to a one year period.

4 Constant currency is calculated by recalculating 2024 revenues using prevailing average foreign exchange rates from 2025 and by recalculating prior period ARR at the prevailing balance sheet date.

 

For further information please contact:

 

 

Big Technologies plc

+44 (0) 19 2360 1910

Ian Johnson (Chief Executive Officer)

Mike Johns (Chief Financial Officer)

Zeus (Nominated Adviser and Joint Broker)

 +44 (0) 203 829 5000

Dan Bate / Kieran Russell (Investment Banking)

Benjamin Robertson (Equity Capital Markets)

Singer Capital Markets (Joint Broker)

+44 (0) 207 496 3000

James Moat / Shaun Dobson / James Todd (Investment Banking)

 

About Big Technologies

Our mission is to deliver innovative, high-quality electronic monitoring solutions that combine advanced hardware and software to support monitoring of individuals in our core criminal justice business. Big Technologies is a market leader in the electronic monitoring industry, operating under the trusted 'Buddi' brand. Through its integrated technology platform, Buddi offers state-of-the-art Electronic Monitoring solutions on a subscription-based, SaaS-like model. This platform is highly flexible and scalable, enabling tailored deployments across diverse use cases and geographies.

For more information, please visit www.buddi.com

Forward-looking statements

This announcement contains certain projections and other forward-looking statements with respect to the financial condition, results of operations, businesses and prospects of Big Technologies PLC. The use of terms such as "may", "will", "should", "expect", "anticipate", "project", "estimate", "intend", "continue", "target" or "believe" and similar expressions (or the negatives thereof) are generally intended to identify forward-looking statements. These statements are based on current expectations and involve risk and uncertainty because they relate to events and depend upon circumstances that may or may not occur in the future. There are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by these forward-looking statements. Any of the assumptions underlying these forward-looking statements could prove inaccurate or incorrect and therefore any results contemplated in the forward-looking statements may not actually be achieved. Nothing contained in this announcement should be construed as a profit forecast or profit estimate. Investors or other recipients are cautioned not to place undue reliance on any forward-looking statements contained herein. Big Technologies PLC undertakes no obligation to update or revise (publicly or otherwise) any forward-looking statement, whether as a result of new information, future events or other circumstances.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFETLAIRFIR
Date   Source Headline
27th May 20267:00 amRNSNotice of AGM
30th Mar 20267:00 amRNSAudited Results for the year to 31 December 2025
26th Feb 20267:00 amRNSHolding(s) in Company
3rd Feb 20267:00 amRNSBoard Changes
2nd Feb 20267:00 amRNSHolding(s) in Company
27th Jan 20267:00 amRNSFull Year Trading Update
19th Jan 20267:00 amRNSFurther Litigation Update
10th Dec 20259:41 amRNSHolding(s) in Company
9th Dec 20259:42 amRNSHolding(s) in Company
8th Dec 20257:00 amRNSTrading Update
3rd Nov 20252:54 pmRNSDirector and PDMR Dealings
16th Oct 20257:01 amRNSWithdrawal of General Meeting Requisition Notice
16th Oct 20257:00 amRNSBoard Changes
3rd Oct 20257:00 amRNSBoard Changes
30th Sep 20257:00 amRNSInterim Results for the 6 months to 30 June 2025
26th Sep 20257:00 amRNSNotice of Requisition of a General Meeting
12th Sep 20257:00 amRNSLitigation Update
20th Aug 20257:00 amRNSChange of Website Address
6th Aug 20257:00 amRNSBoard Change and Issue of Shares
1st Aug 20257:00 amRNSIssue of Shares
28th Jul 20257:00 amRNSBoard Changes
22nd Jul 20257:00 amRNSTrading Update
18th Jun 20252:53 pmRNSResult of AGM and Litigation Update
13th Jun 20258:12 amRNSPublication of Letter to Shareholders
10th Jun 20251:27 pmRNSSuspension of Voting Rights and Letter Response
5th Jun 20257:00 amRNSLitigation Update
22nd May 20259:45 amRNSDirector Dealings
22nd May 20257:00 amRNS2024 Audited Results and Notice of AGM
16th May 20257:00 amRNSAppointment of Joint Corporate Broker
8th May 20257:00 amRNSBoard and Management Changes and Trading Update
7th Apr 20257:00 amRNSAppointment of Non Executive Director
3rd Apr 20257:00 amRNSUpdate re: CEO Dismissal
1st Apr 20257:00 amRNS-RContract Award
1st Apr 20257:00 amRNSDirectorate Change
1st Apr 20257:00 amRNSTransaction in Own Shares
31st Mar 20255:20 pmRNSCEO Dismissal and Commencement of Litigation
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20257:00 amRNSHolding(s) in Company
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 202511:13 amRNSLitigation Update
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 202512:51 pmRNSCEO Suspension
18th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.